Corinne Boyer Chair

Patrick Boyer presenting Barbara Vanderhyden with a photograph of Corinne Boyer

In 1995, at the age of 57, Corinne Boyer died of ovarian cancer. This remarkable woman had survived two bouts of cancer - a malignant melanoma in 1979 and a breast lump in 1991, before her final struggle with ovarian cancer. Undaunted by her experience with the deadly cancer, Corinne often said, "I've got the cancer, but the cancer does not have me." She had spent years crusading for women's rights, endangered species, and the environment. In the months before she died, and largely because of her experiences with cancer, she fought for increased funding for women's health research.

One of Corinne's favourite sayings was "Go where there is no path and leave a trail". This message became a reality in 1997 when her husband Patrick Boyer founded the Corinne Boyer Fund, with the aim of furthering research into ovarian cancer and to raise awareness of the disease in Canada. Dedicated research effort to address this deadly cancer was a long time in coming. Patrick Boyer recognized that, and has to be given full credit for turning his frustration and anger into a passion that motivated him to move mountains in his effort to raise awareness and funds for this disease.

In 1998, the Corinne Boyer Fund (which became the National Ovarian Cancer Association, NOCA, and then Ovarian Cancer Canada) and the University of Ottawa announced the establishment of the Corinne Boyer Chair in Ovarian Cancer Research in the Faculty of Medicine. The Chair was established with a million-dollar donation from NOCA that was matched by the University of Ottawa. Ottawa was selected for the location of the Chair because of its existing strong multidisciplinary network of people who are committed to finding better ways to detect and treat ovarian cancer.

In October of 2000, Dr. Barbara Vanderhyden was appointed to the Chair. The new Chair is part of a dynamic multidisciplinary group of investigators in the University of Ottawa's Department of Cellular and Molecular Medicine, and the Department of Obstetrics and Gynaecology, Division of Gynecologic Oncology.

Please explore this website for details on the Launch of the Chair, on the Vision established by the Chair when she accepted this position, and the progress reports describing her activities and achievements.